Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-randomized Observational Study to Collate Data Regarding the Safety, Efficacy and Satisfaction of ReX® in the Management of Solid Oral Medications.

NCT06335758 is registered in ClinicalTrials.gov with Dosentrx Ltd. as lead sponsor.

NCT NCT06335758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06335758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-randomized Observational Study to Collate Data Regarding the Safety, Efficacy and Satisfaction of ReX® in the Management of Solid Oral Medications.
Lead sponsor
Dosentrx Ltd.
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2024
Completion date
January 31, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

any solid oral medication